Diagnostic center for primary care patients with nonspecific symptoms and suspected cancer: compliance to workflow and accuracy of tests and examinations

References

• Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(1):S92–S107.
   PubMedGoogle Scholar
• Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909–919.
   PubMed Web of Science ®Google Scholar
• Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–1126.
   PubMed Web of Science ®Google Scholar
• Torring ML, Frydenberg M, Hamilton W, et al. Diagnostic interval and mortality in colorectal cancer: u-shaped association demonstrated for three different datasets. J Clin Epidemiol. 2012;65(6):669–678.
   PubMed Web of Science ®Google Scholar
• Torring ML, Frydenberg M, Hansen RP, et al. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer. 2011;104(6):934–940.
   PubMed Web of Science ®Google Scholar
• Torring ML, Frydenberg M, Hansen RP, et al. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49(9):2187–2198.
   PubMed Web of Science ®Google Scholar
• Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009;101( 2):S125–S129.
   PubMedGoogle Scholar
• Rutqvist LE. Waiting times for cancer patients-a “lippery slope” in oncology. Acta Oncol. 2006;45(2):121–123.
   PubMed Web of Science ®Google Scholar
• McCutchan G, Wood F, Smits S, et al. Barriers to cancer symptom presentation among people from low socioeconomic groups: a qualitative study. BMC Public Health. 2016;16(1):1052.
   PubMedGoogle Scholar
• Ingebrigtsen SG, Scheel BI, Hart B, et al. Frequency of ‘warning signs of cancer’ in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013;30(2):153–160.
   PubMed Web of Science ®Google Scholar
• Jensen H, Torring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14:636.
   PubMed Web of Science ®Google Scholar
• Nielsen TN, Hansen RP, Vedsted P. [Symptom presentation in cancer patients in general practice]. Ugeskr Laeger. 2010;172(41):2827–2831.
   PubMedGoogle Scholar
• Stenman E, Palmer K, Ryden S, et al. Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer. Acta Oncol. 2019;58(3):296–305.
   PubMed Web of Science ®Google Scholar
• The Norwegian Directorate of Health. Diagnostisk pakkeforløp for pasienter med uspesifikke symptomer på alvorlig sykdom som kan vaere kreft [Diagnostic package for patients with non-specific symptoms of severe disease that may be cancer]. Norway: The Norwegian Directorate of Health; 2016.
   Google Scholar
• Vedsted P, Olesen F. A differentiated approach to referrals from general practice to support early cancer diagnosis – the Danish three-legged strategy. Br J Cancer. 2015;112(1):S65–S69.
   PubMedGoogle Scholar
• Bislev LS, Bruun BJ, Gregersen S, et al. Prevalence of cancer in Danish patients referred to a fast-track diagnostic pathway is substantial. Danish Med J. 2015;62(9):A5138.
   PubMed Web of Science ®Google Scholar
• Ingeman ML, Christensen MB, Bro F, et al. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15(1):421.
   PubMedGoogle Scholar
• Nicholson BD, Oke J, Friedemann Smith C, et al. The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer. BMJ Open. 2018;8(1):e018168.
   PubMed Web of Science ®Google Scholar
• The National Board of Health Copenhagen. Diagnostisk pakkeforløb for patienter med uspecifikke symptomer på alvorlig sygdom, der kunne vaere kraeft [Diagnostic pathway for patients with non-specific symptoms of serious illness that might be cancer].København, Denmark: The National Board of Health Copenhagen; 2012.
   Google Scholar
• Stenman E, Sundquist J. Diagnostiskt centrum för snabbare diagnos. Allmänmedicin. 2015;4:25–26.
   Google Scholar
• Allemani C, Matsuda T, DiCarlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075.
   Google Scholar
• Moseholm E, Lindhardt BO. Patient characteristics and cancer prevalence in the Danish cancer patient pathway for patients with serious non-specific symptoms and signs of cancer-a nationwide, population-based cohort study. Cancer Epidemiol. 2017;50(Pt A):166–172.
   PubMed Web of Science ®Google Scholar
• The Regional Cancer Centers Sweden. Standardiserade vårdförlopp. Förkortade versioner för primärvården [Standardized cancer care pathways. Short-versions for primary care]. Regionala cancercentrum i samverkan, Stockholm, Sweden.2020.
   Google Scholar
• Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235(2):288–297.
   PubMed Web of Science ®Google Scholar
• Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018;10(8):408.
   PubMed Web of Science ®Google Scholar
• Robinot R, Bachy E, Chaubard S, et al. Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis. Blood. 2018;132(25):2691–2695.
   PubMed Web of Science ®Google Scholar
• Schollkopf C, Melbye M, Munksgaard L, et al. Borrelia infection and risk of non-Hodgkin lymphoma. Blood. 2008;111(12):5524–5529.
   PubMed Web of Science ®Google Scholar
• Chang CM, Landgren O, Koshiol J, et al. Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden. Int J Cancer. 2012;131(9):2208–2209.
   PubMed Web of Science ®Google Scholar
• Holland-Bill L, Christiansen CF, Farkas DK, et al. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study. Acta Oncol. 2018;57(4):522–527.
   PubMed Web of Science ®Google Scholar